Author(s):
Colorectal cancer (CRC) ranks among the most prevalent and deadly cancers worldwide. Early detection plays a crucial role in improving patient outcomes. Biomarkers have emerged as promising tools for enhancing the early detection and prognosis of CRC, offering potential for more effective screening strategies. This article reviews current and novel biomarkers for CRC, their roles in early detection, and discusses challenges and future prospects for clinical implementation.
